1. Home
  2. WIA vs GNFT Comparison

WIA vs GNFT Comparison

Compare WIA & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WIA
  • GNFT
  • Stock Information
  • Founded
  • WIA 2003
  • GNFT 1999
  • Country
  • WIA United States
  • GNFT France
  • Employees
  • WIA N/A
  • GNFT N/A
  • Industry
  • WIA Trusts Except Educational Religious and Charitable
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WIA Finance
  • GNFT Health Care
  • Exchange
  • WIA Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • WIA 192.9M
  • GNFT 186.3M
  • IPO Year
  • WIA N/A
  • GNFT 2019
  • Fundamental
  • Price
  • WIA $8.39
  • GNFT $3.83
  • Analyst Decision
  • WIA
  • GNFT Strong Buy
  • Analyst Count
  • WIA 0
  • GNFT 1
  • Target Price
  • WIA N/A
  • GNFT $13.00
  • AVG Volume (30 Days)
  • WIA 39.2K
  • GNFT 4.0K
  • Earning Date
  • WIA 01-01-0001
  • GNFT 04-24-2025
  • Dividend Yield
  • WIA 12.29%
  • GNFT N/A
  • EPS Growth
  • WIA N/A
  • GNFT N/A
  • EPS
  • WIA N/A
  • GNFT 0.03
  • Revenue
  • WIA N/A
  • GNFT $73,187,701.00
  • Revenue This Year
  • WIA N/A
  • GNFT $15.98
  • Revenue Next Year
  • WIA N/A
  • GNFT N/A
  • P/E Ratio
  • WIA N/A
  • GNFT $121.41
  • Revenue Growth
  • WIA N/A
  • GNFT 105.01
  • 52 Week Low
  • WIA $7.56
  • GNFT $2.55
  • 52 Week High
  • WIA $8.91
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • WIA 62.67
  • GNFT 41.57
  • Support Level
  • WIA $8.25
  • GNFT $3.44
  • Resistance Level
  • WIA $8.44
  • GNFT $3.81
  • Average True Range (ATR)
  • WIA 0.06
  • GNFT 0.17
  • MACD
  • WIA -0.00
  • GNFT -0.01
  • Stochastic Oscillator
  • WIA 58.82
  • GNFT 38.18

About WIA Western Asset Inflation-Linked Income Fund

Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation. Under normal market conditions and at the time of purchase, the Fund will invest at least 80% of its total managed assets in inflation-linked securities and at least 60% of its total managed assets in U.S. Treasury Inflation Protected Securities (TIPS). The Fund may also invest up to 40% of its total managed assets in non-U.S. dollar investments.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: